SANA insider transaction filings
Sana Biotechnology, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-27. Screen SANA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| PATEL DHAVALKUMAR DHIRAJLAL — EVP, Chief Scientific Officer | 1 | — | — | 3 |
| Bishop Hans Edgar — Director | 1 | — | — | 1 |
Recent Form 4 filings — Sana Biotechnology, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | PATEL DHAVALKUMAR DHIRAJLAL — EVP, Chief Scientific Officer | Option exercise (M): 125,000 @ $0 · Tax withholding (F): 41,158 @ $4.11 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 6,297 @ $0 | EDGAR |
| 2026-06-05 | 4 | Seitz Michelle — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | REICIN ALISE — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Rosiello Robert L. — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Bilenker Joshua H. — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Mulligan Richard — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Yang Patrick Y — Director | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | NELSEN ROBERT — Director, 10% owner | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 7,763 @ $0 | EDGAR |
| 2026-03-10 | 4 | Harr Steve — President & CEO, Director | Option exercise (M): 41,666 @ $0 · Option exercise (M): 50,000 @ $0 · Tax withholding (F): 11,526 @ $3.13 · Tax withholding (F): 12,819 @ $3.10 · Option exercise (M): 41,666 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 10,416 @ $0 · Option exercise (M): 3,250 @ $0 · Tax withholding (F): 3,342 @ $3.13 · Tax withholding (F): 1,045 @ $3.10 · Option exercise (M): 10,416 (derivative) @ $0 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Harr Steve — President & CEO, Director | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Wyrick Susan D. — See Remarks | Grant/award (A): 45,833 (derivative) @ $0 · Grant/award (A): 206,250 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 1,525 @ $0 · Tax withholding (F): 491 @ $3.91 · Option exercise (M): 1,525 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Piper Brian — EVP, Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 2,407 @ $4.27 · Option exercise (M): 7,500 (derivative) | EDGAR |
| 2026-01-06 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 6,157 @ $0 | EDGAR |
| 2025-12-16 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 3,400 @ $0 · Tax withholding (F): 873 @ $5.22 · Option exercise (M): 3,400 (derivative) | EDGAR |
| 2025-12-05 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 10,000 @ $0 · Tax withholding (F): 2,567 @ $2.32 · Option exercise (M): 10,000 @ $0 · Tax withholding (F): 2,565 @ $4.44 · Grant/award (A): 3,400 (derivative) @ $0 · Grant/award (A): 5,100 (derivative) @ $0 · +2 more | EDGAR |
| 2025-10-07 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 5,628 @ $0 | EDGAR |
| 2025-07-08 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 7,842 @ $0 | EDGAR |
| 2025-06-09 | 4 | Seitz Michelle — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | REICIN ALISE — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Rosiello Robert L. — Director | Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Bilenker Joshua H. — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Mulligan Richard — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Yang Patrick Y — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | NELSEN ROBERT — Director, 10% owner | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Wilderotter Mary Agnes — Director | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 16,339 @ $0 | EDGAR |
| 2025-03-10 | 4 | Harr Steve — President & CEO, Director | Option exercise (M): 50,000 @ $0 · Tax withholding (F): 12,820 @ $2.56 · Grant/award (A): 166,667 (derivative) @ $0 · Grant/award (A): 750,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 3,250 @ $0 · Tax withholding (F): 836 @ $2.56 · Grant/award (A): 41,667 (derivative) @ $0 · Grant/award (A): 187,500 (derivative) @ $0 · Option exercise (M): 3,250 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Cassidy Bernard J — EVP & General Counsel | Option exercise (M): 11,041 @ $0 · Tax withholding (F): 2,833 @ $2.56 · Grant/award (A): 53,333 (derivative) @ $0 · Grant/award (A): 240,000 (derivative) @ $0 · Option exercise (M): 11,041 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 1,525 @ $0 · Tax withholding (F): 490 @ $2.56 · Option exercise (M): 1,525 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | FMR LLC — 10% owner | Sale (S): 100,000 @ $6.11 · Sale (S): 25,000 @ $6.50 · Sale (S): 164,912 @ $6.71 · Sale (S): 1,000 @ $7.26 | EDGAR |
| 2025-01-07 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 14,285 @ $0 | EDGAR |
| 2025-01-03 | 4 | Wyrick Susan D. — See Remarks | Option exercise (M): 5,000 @ $0 · Tax withholding (F): 1,566 @ $1.65 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-10-09 | 4 | Bishop Hans Edgar — Director | Grant/award (A): 5,938 @ $0 | EDGAR |
| 2024-09-26 | 4 | Mulligan Richard — Director | Sale (S): 150,000 @ $4.08 · Sale (S): 150,000 @ $3.89 | EDGAR |
| 2024-07-15 | 4/A | REICIN ALISE — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Bilenker Joshua H. — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Cole Douglas G. — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Bishop Hans Edgar — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Mulligan Richard — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Yang Patrick Y — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | NELSEN ROBERT — Director, 10% owner | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Wilderotter Mary Agnes — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Sana Biotechnology, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SANA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →